Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer

Supporting evidence

• Review decision

• Review Decision – June 2016

• Review Decision Paper (PDF 98 KB)

  Published:

  13 June 2016